Cargando…
An overview of prevalence, determinants and health outcomes of polypharmacy
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are likely to be on a polypharmacy regime, is lim...
Autores principales: | Khezrian, Mina, McNeil, Chris J., Murray, Alison D., Myint, Phyo K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294476/ https://www.ncbi.nlm.nih.gov/pubmed/32587680 http://dx.doi.org/10.1177/2042098620933741 |
Ejemplares similares
-
The association between polypharmacy and late life deficits in cognitive, physical and emotional capability: a cohort study
por: Khezrian, Mina, et al.
Publicado: (2018) -
A Review of Frailty Syndrome and Its Physical, Cognitive and Emotional Domains in the Elderly
por: Khezrian, Mina, et al.
Publicado: (2017) -
Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
por: Barlow-Pay, Fenella, et al.
Publicado: (2021) -
RATIONALE FOR ASPREE DISABILITY-FREE SURVIVAL PRIMARY OUTCOME AND OVERVIEW OF PRIMARY OUTCOME RESULTS
por: McNeil, John
Publicado: (2019) -
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
por: Castioni, Julien, et al.
Publicado: (2017)